High-frequency magnetic stimulation attenuates beta-amyloid protein 1-42 neurotoxicity in organotypic hippocampal slices

Neural Regeneration Research

Volumn 5, Issue 18, 2010, Pages 1365-1372

  Kim, Don Kyu ^a   Yoon, Young Chul ^a   Chae, Soo Ahn ^a   Seo, Kyung Mook ^a   Han, Tai Ryoon ^b   Kang, Si Hyun ^a  

^a Chung Ang University College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Amyloid beta protein; Hippocampus; Magnetic stimulation; Nerve degeneration metabolism; Nerve degeneration pathology; Organ culture techniques; Organotypic; Rats; Sprague dawley

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; BROXURIDINE; LACTATE DEHYDROGENASE; PROPIDIUM IODIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE MEDIUM; DIATHERMY; ENZYME ACTIVITY; FLUORESCENCE ANALYSIS; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; NERVE CELL LESION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PROTEIN EXPRESSION; RAT; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 79960362137     PISSN: 16735374     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1673-5374.2010.18.001     Document Type: Article

References (37)

1. George M, Lisanby S, Sackeim H. Transcranial Magnetic stimulation. Arch Gen Psychiatry. 1999;56:300-311.
2. Rossini PM, Rossi S. Clinical applications of motor evoked potentials. Electroenceph Clin Neurophysiol. 1998;106:180-194.
3. Post A and Keck ME. Transcranial magnetic stimulation as a therapeutic tool in psychiatry: what do we know about the neurobiological mechanisms? J Psychiatr Res. 2001;35:193-215.
4. Daskalakis ZJ, Levinson AJ, Fitzgerald PB. Repetitive transcranial magnetic stimulation for major depressive disorder: a review. Can J Psychiatry. 2008;53:555-566.
5. Keck ME, Sillaber I, Ebner K, et al. Acute transcraniaí magnetic stimulation of frontal brain regions selectively modulates the release of vasopressin, Diogenic amines and amino acids in the rat brain. Eur J Neurosci. 2000;12:3713-3720.
6. Ben-Shachar D, Belmaker RH, Grisaru N, et al. Transcranial magnetic stimulation induces alterations in brain monoamines. J Neural Transm 1997;104:191-197.
7. Speer AM, Kimbrell TA, Wassermann EM, et al. Opposite effects of high and low frequency rTMS on regional brain activity in depressed patients. Biol Psychiatry. 2000;48:1133-1141.
8. Kole MHP, Fuchs E, Ziemann U, et al. Changes in 5-HT1A and NMDA binding sites by a single rapid transcranial magnetic stimulation procedure in rats. Brain Res. 1999;826:309-312.
9. Post A, Müller MB, Engelmann M, et al. Repetitive transcranial magnetic stimulation in rats: evidence for a neuroprotective effect in vitro and in vivo. Eur J Neurosci 1999;11:3247-3254.
10. Fujiki M, Kobayashi H, Abe T, et al. Repetitive transcranial magnetic stimulation for protection against delayed neuronal death induced by transient ischemia. J Neurosurg. 2003;99: 1063-1069.
11. Ogiue-Ikeda M, Kawato S, Ueno S. Acquisition of ischemic tolerance by repetitive transcranial magnetic stimulation in the rat hippocampus. Brain Res. 2005;1037:7-11.
12. Forloni G. Beta-amyloid neurotoxicity. Funct Neurol. 1993;8: 211-225.
13. Forloni G. Neurotoxicity of β-amyloid and prion pepetides. Curr Opion Neurol. 1996;9:492-500.
14. Behl C, Davis JB, Lesley R, et al. Hydrogen peroxide mediates Amyloid protein toxicity. Cell 1994;77:817-827.
15. Behl C. Oxidative stress in alzheimer's disease: Implications for prevention and therapy. Subcell Biochem. 2005;38:65-78.
16. Ekinci F, Linsley M, Shea T. Beta-Amyloid-induced calcium influx induces apoptosis in culture by oxidative stress rather than tau phosphorylation. Brain Res Mol Brain Res. 2000;76:389-395.
17. Mattson MP, Cheng B, Davis D, et al. ß-amyloid peptides destabilize calcium homeostasis and render human conical neurons vulnerable to excitoxicity. J Neurosci. 1991;12:376-389.
18. Copani A, Koh lY, Cotman CW. Beta-amyloid increases neuronal susceptibility to injury by glucose deprivation. Neuroreport. 1991;2: 763-765.
19. Zhang Z, Rydel RE, Drzewiecki GJ, et al. Amyloid beta-mediated oxidative and metabolic stress in rat cortical neurons: No direct evidence for a role for H2O2 generation. J Neurochem. 1996;67:1595-1606.
20. Bruce AJ, Malfroy B, Baudry M. Beta-amyloid toxicity in organotypic hippocampal cultures: Protection by euk-8, a synthetic catalytic free radical scavenger. Proc Natl Acad Sci U S A. 1996;93:2312-2316.
21. Goodman Y, Steiner MR, Steiner SM, et al. Nordihydroguaiaretic acid protects hippocampal neurons against amyloid beta-peptide toxicity and attenuates free radical and calcium accumulation. Brain Res. 1994;654:171-176.
22. Forloni G, Chiesa R, Smiroldo S, et al. Apoptosis mediated neurotoxicity induced by chronic application of beta amyloid fragment 25-35. Neuroreport. 1993;4(5):523-526.
23. Hong SC, Youn YC, Lee DK, et al. Organotypic slice culture of rat hippocampus for neuroscience research. Korean Child Neurol Soc. 2003;11:13-19.
24. Youn YC, Kwon OS, Chae SA. The Bcl-2 and NeuN expressions and orphological changes in organotypic explant culture of rat hippocampus. Korean Neurol Assoc. 2004;22:368-374.
25. Nitsch R, Farber SA, Growdon JH, et al. Release of amyloid ß-protein precursor derivatives by electrical depolarization of rat hippocampal slices. Proc Natl Acad Sci U S A. 1993;90: 5191-5193.
26. Van Nostrand WE, Wagner SL, Shankle WR, et al. Decreased levels of soluble amyloid beta protein precursor in cerebrospinal fluid of live Alzheimer disease patients. Proc Natl Acad Sci U S A. 1992;H9:2551-2555.
27. White A, Zheung H, Galatis D, et al. Survival of cultured neurons form amyloid precursor protein knock-out mice against Alzheimer's amyloid-ß toxicity and oxidative stress. J Neurosci. 1998;18:6207-6217.
28. Mattson M. Cellular actions of precursor protein and its soluble and fibillogenic derivatives. Physiol Rev. 1997;77:1081-1132.
29. Müller MB, Toschi N, Kresse AE, et al. Long-term repetitive transcranial magnetic stimulation increases the expression of brain-derived neurotrophic factor and cholecystokinin mRNA, but not neuropeptide tyrosine mRNA in specific areas of rat brain. Neuropsychopharmacology. 2000;23:205-215.
30. De Simoni A, Griesinger CB, Edwards FA. Development of rat CA1 neurones in acute versus organotypic slices: role of experience in synaptic morphology and activity. J Physiol. 2003; 550:135-147.
31. Raineteau O, Rietschin L, Gradwohl G, et al. Neurogenesis in hippocampal slice cultures. Mol Cell Neurosci. 2004;26:241-250.
32. Wassermann EM, Grafman J, Berry C, et al. Use and safety of a new repetitive transcranial magnetic stimulator. Electroencephalogr Clin Neurophysiol. 1996;101:412-417.
33. Wassermann EM. Risk and safety of repetitive transcranial magnetic stimulation: report and suggested guidelines from the International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation, June 5-7, 1996. Electroencephalogr Clin Neurophysiol. 1998;108:1-16.
34. Han TR, Kim JH, Chung SG, et al. Optimization of facilitation threshold in transcranial magnetic stimulation. J Korean Acad Rehabil Med. 1998;22:1263-1270.
35. Yoo WK, Chung GI, Lee JH, et al. The effect of sub-threshold 1 Hz and 20 Hz repetitive transcranial magnetic stimulation on corticospinal excitability. J Korean Acad Rehabil Med. 2003;27: 922-927.
36. Bares M, Kopecek M, Novak T, et al. Low frequency (1-Hz), right prefrontal repetitive transcranial magnetic stimulation (rTMS) compared with venlafaxine ER in the treatment of resistant depression: A double-blind, single-centre, randomized study. J Affect Dis. 2009;118:94-100.
37. Malouf AT. Effect of beta amyloid peptides on neurons in hippocampal slice cultures. Neurobiol Aging. 1992;13:543-551.